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I In nt tr ro od du uc ct ti io on n 
Tricuspid regurgitation (TR) is a common finding in patients
who have previously undergone left-sided valve surgery.
1)2) De-
termining the optimal time for corrective surgery remains a
difficult clinical problem in patients with severe TR. Subjective
symptoms in patients with severe TR are often non-specific,
progress very slowly, and only become evident after irreversible
right ventricular (RV) dysfunction occurs. Echocardiographic
or cardiac magnetic resonance (CMR) measurement of the
complex geometry of the RV have been investigated to predict
the impact of TR on long-term prognosis independent of the
left ventricular (LV) ejection fraction or pulmonary artery pres-
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B Ba ac ck kg gr ro ou un nd d: : The plasma B-type natriuretic peptide (BNP) level is a useful prognostic marker in heart failure and valvular heart
disease. In patients with isolated severe tricuspid regurgitation (TR), little is known about the determinants of plasma BNP levels
and the correlation with future outcome. The purpose of this study was to identify the determinants of plasma BNP levels in
patients with isolated severe TR and the value of the BNP level in predicting postoperative outcomes after corrective surgery.
M Me et th ho od ds s: : We prospectively enrolled 39 patients with isolated, severe TR undergoing corrective surgery. A plasma BNP assay
and cardiac magnetic resonance (CMR) imaging were performed before surgery. The combined end-point was the occurrence
of cardiac death or readmission due to heart failure. 
R Re es su ul lt ts s: : Linear regression analysis showed that the left ventricular ejection fraction and right ventricular end systolic volume
were the most important determinants of the BNP levels (p = 0.002, R
2 = 0.315). Based on the receiver operating
characteristics (ROC) curve, we were able to derive an optimal cutoff value (200 pg/mL) to predict postoperative cardiac death
with a sensitivity of 80% and a specificity of 85%. The one-year survival rate was 96% in patients with a BNP < 200 pg/mL
and 53% in patients with a BNP ≥200 pg/dL (p = 0.001). 
C Co on nc cl lu us si io on n: : An elevation in the BNP level is determined by the functional status of the right and left ventricles in patients
with isolated, severe TR. An elevated BNP predicts adverse events after corrective surgery. Therefore, the BNP level should be
included in the clinical evaluation and risk stratification of patients with isolated TR.  
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3)4) because high surgical mortality and morbidity have
been reported in these patients;
5-7)  however, it is extremely
difficult to obtain accurate and reproducible information
regarding RV haemodynamics in a quantitative manner using
echocardiography, the technique most frequently used to assess
cardiac haemodynamics.
8) Although CMR imaging has
emerged as the reference standard imaging modality for quan-
titative assessment of RV volumes, systolic function, and valve
function, CMR imaging is not readily available because of the
high cost, and CMR imaging is a time-consuming process.
Therefore, it is of paramount importance to provide a surrogate
marker to predict clinical outcomes after surgery and to deter-
mine surgical timing for patients with severe TR. B-type
natriuretic peptide (BNP) is primarily secreted from the cardiac
ventricles in response to ventricular volume and pressure over-
load;
9)10) the stimulus for BNP release is an increase in ventri-
cular wall stress.
11) The plasma BNP level is elevated in patients
with heart failure
12) and hypertrophy.
13) In patients with val-
vular heart disease, such as aortic stenosis and mitral regurgita-
tion, increased levels of BNP correlate with poor functional
capacity, the severity of valve disease, and the clinical out-
come;
14)15) however, there, have been no studies dealing with
this important issue in patients with TR. In the present study,
we prospectively enrolled patients with isolated severe TR to
evaluate the role of BNP as a predictor of clinical outcomes
after surgery.
M Me et th ho od ds s
Study subjects
We prospectively enrolled consecutive patients with isolated
severe TR who underwent corrective surgery between Jan-
uary 2006 and March 2009. All patients satisfied the follow-
ing 3 criteria for severe TR: (1) a TR jet area > 30% of the
right atrial area; (2) inadequate cusp coaptation; and (3)
systolic flow reversal in the hepatic vein. Patients with signi-
ficant left-sided valve disease who underwent concomitant
left-sided valve surgery were excluded from the study. Ulti-
mately, 39 patients were enrolled. The mean patient age was
55.9 years of age; 33 patients (84.6%) were women. In all
patients, CMR imaging was performed before surgery and
clinical follow-up was performed after surgery. The occur-
rence of clinical events was determined by reviewing the hos-
pital records and telephone interview if needed. The study
protocol was approved by the Institutional Review Board of
Seoul National University Hospital.
BNP assay
All of the venous blood samples were collected in EDTA
tubes for measurement of BNP levels. Assays for BNP were
performed with a triage B-type Natriuretic Peptide test (Bio-
site Diagnostics, Inc., San Diego, CA, USA) which is a fluo-
rescence immunoassay for the quantitative determination of
BNP in whole blood and plasma specimens. The triage B-type
Natriuretic Peptide test has a turnaround time of 15 minutes
and a measurement range of 5 - 5,000 pg/mL; this method
correlates the fluorescence measurement to the BNP concen-
tration using an internal calibration curve. The pre-operative
BNP levels were obtained within 1 week prior to surgery.
CMR imaging
CMR imaging examinations were performed on a 1.5 Tesla
system (Sonata Magnetom, Siemens, Erlangen, Germany). All
images were acquired by a phased-array body surface coil dur-
ing breath holds, and were electrocardiogram-triggered. After
localizer imaging, cine true-fast imaging with steady-state
precession imaging (TrueFISP; repetition time/echo time, 45
ms/1.3 ms; flip angle 80˚; matrix 256×169; field of view 330
×330 mm; slice thickness, 8 mm) was performed in several
long-axis planes (2-, 3-, and 4-chamber views) of the heart.
Parallel short-axis sections from the valve plane to the apex
were acquired for volumetric analysis. Velocity-encoding cine
CMR imaging with free breathing and prospective electro-
cardiography (ECG) gating (repetition time/echo time, 45
ms/3.2 ms; flip angle 30˚; matrix 256×238; field of view 330
×330 mm; slice thickness, 5 mm) was performed in a plane
orthogonal to the right and left pulmonary arteries to allow
net forward volume of right ventricle (RV) to be calculated.
RV and LV end-diastolic (EDV) and end-systolic volumes
(ESV), stroke volume, cardiac output, ejection fraction (EF),
and flow profiles of the right and left pulmonary arteries were
measured by one independent observer on a personal com-
puter using dedicated software (QMASS MR; Medis, Leiden,
The Netherlands). Ventricular volumes, stroke volume, and
cardiac output were corrected for body surface area. The
amount of TR was calculated by subtracting the net pul-
monary blood volume of the right and left pulmonary arteries
from the RV stroke volume. The TR fraction was calculated
by dividing the TR amount by the RV stroke volume (ex-
pressed as a percentage). 
Statistical analysis
Data are expressed as the mean ± SEM or median (range)
for continuous variables and as numbers (percentages) for
categorical variables. For comparison of continuous and cate-
gorical variables between patients with clinical events and
those without clinical events, the Mann-Whitney U test and
Fisher exact test were used, respectively. Clinical end points
or events were defined as cardiac death and readmission due
to heart failure. Using receiver operating characteristic (ROC)
curves, we examined the sensitivities and specificities of vari-
ous cut-off points that reliably predicted cardiac deaths.
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based on the likelihood ratio test was used to determine inde-
pendent variables for the level of BNP. A Kaplan-Meier
curve was constructed to demonstrate the survival difference
in relation to the cut-off level of BNP according to the pre-
sence or absence of cardiac deaths with the use of the log-
rank test. SPSS (version 17.0) was used for statistical analyses.
pvalues < 0.05 were considered statistically significant.
R Re es su ul lt ts s 
Baseline characteristics 
Thirty-nine patients were included in the analysis; their
baseline characteristics of the patients are shown in Table 1.
Thirty-seven patients (95%) had previous left-sided valve
surgery. Three of the 37 patients underwent tricuspid valve
surgery. Two patients (5%) had no previous cardiac surgery.
The pulmonary artery systolic pressure, as estimated by echo-
cardiography, was not elevated, suggesting LV dysfunction
did not affect the development of isolated TR in this group
of patients. The median BNP level was 64 pg/mL and the
interquartile range (25 - 75%) was 40 - 181 pg/mL. The
CMR variables are described in Table 2. End diastolic and
end systolic RV volume were significantly increased. In
contrast to the RV volume, the LV volume was mildly increas-
ed and the mean LV EF was normal. 
RV ESV index and LV EF determine the plasma BNP 
level in patients with isolated, severe TR 
To identify important CMR determinants associated with the
plasma BNP level in patients with isolated, severe TR, we
performed linear regression analysis with the forward stepwise
selection method (criteria to include, probability of F < 0.050;
criteria to exclude, probability of F > 0.100). The dependent
variable was the value of logarithmic transformation of the
plasma BNP level because distribution of BNP level was not
normal. Logarithmic transformation resulted in a normal distri-
bution of the dependent variable which was evaluated by Kol-
mogorov-Smirnov test. The independent variables were CMR
parameters. The LV EF and RV ESV were the 2 most impor-
tant determinants of the plasma BNP level [p = 0.002, R
2 =
0.315, logBNP = 0.003×[RV end systolic volume index
(ESVI)] - 0.014×(LV EF) + 2.346]. Regression diagnostics by
residual plots revealed no relevant violations. On ROC curve
analysis, we found that a LV EF of 46% (sensitivity, 75%; and
specificity, 85%) and RV ESVI 140 mL/m
2(sensitivity, 86% and
specificity, 85%) predicted a BNP ≥200 pg/mL most effectively. 
Plasma BNP level predicts cardiac death after 
open heart surgery for isolated, severe TR 
The area of the ROC curve relating BNP levels to post-
operative mortality was 0.788 (95% confidence interval:
0.573 - 1.003; p = 0.04)(Fig. 1). Based on the ROC curve,
we were able to derive an optimal cut-off value (200 pg/mL)
to predict post-operative cardiac death. 
The baseline characteristics of patients according to BNP
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Table 1. Baseline characteristics 
Baseline characteristics  Value
Age (year) 55.9 ± 1.5 
Female gender, n (%) 33 (84.6)
BMI (kg/m
2) 21.6 ± 0.4
SBP (mmHg) 112.9 ± 1.80
Exercise capacity (sec) 699 ± 52
NYHA Fc
II 15 
III 20
IV 3
Previous operation
MVP 3
MVR 14
MVR + AVR 17
MVR + TAP or TVP  3
None 2
PASP (mmHg) 39.3 ± 1.3
Atrial fibrillation, n (%)  33 (84.6)
Creatinine (mg/dL) 1.08 ± 0.04
Cholesterol (mg/dL) 142 ± 60
Albumin (g/dL) 3.8 ± 0.1
Hemoglobin (g/dL) 11.6 ± 0.3
Medication
Digoxin, n (%)  28 (71.8)
ACE inhibitor, n (%)  5 (12.8)
Beta-blocker, n (%)  6 (15.4)
Diuretics, n (%)   28 (71.8)
Spironolactone, n (%)  30 (76.9)
Values: mean ± SEM. BMI: body mass index, SBP: systolic blood pressure, 
exercise capacity: exercise time on treadmill by Bruce protocol, NYHA Fc:
New York Heart Association Functional class, MVP: mitral valvuloplasty,
MVR: mitral valve replacement, AVR: aortic valve replacement, TAP:
tricuspid annuoplasty, TVP: tricuspid valvuloplasty, PASP: estimated
pulmonary artery systolic pressure by echocardiography
Table 2. CMR variables
CMR variables Value
RV EDVI (mL/m
2) 204 ± 12
RV ESVI(mL/m
2) 118 ± 8
RV EF (%) 44.3 ± 1.6
RV CI (L/min/m
2) 6.01 ± 0.32
LV EDVI(mL/m
2) 94 ± 5
LV ESVI(mL/m
2) 41 ± 4
LV EF (%) 57.7 ± 2.2
LV CI (L/min/m
2) 3.69 ± 0.16
Values: mean ± SEM. CMR: cardiac magnetic resonance, RV: right 
ventricle,LV: left ventricle, EDVI: end diastolic volume index, ESVI: end
systolic volume index, EF: ejection fraction, CI: cardiac indexlevel are compared in Table 3. No significant differences were
observed between both groups with respect to age, gender,
body mass index, exercise capacity, and the presence of atrial
fibrillation. Patients with a BNP level ≥ 200 pg/mL had a
significantly higher New York Heart Association functional
class and a lower level of serum creatinine, cholesterol, albu-
min, and hemoglobin. Among baseline characteristics, the
serum albumin level was the most important factor in deter-
mining the plasma BNP level [R
2 = 0.258, p = 0.004,
logBNP = 3.219 - 0.324×(albumin)]. The pulmonary artery
systolic pressure, as estimated by echocardiography, was not
different between the two groups, suggesting that the RV
afterload was comparable between the groups.  
The CMR variables of patients according to BNP level are
compared in Table 4. RV volume was significantly larger and
LV EF was significantly lower in the patients with a BNP
level ≥ 200 pg/mL that in the patients with a BNP level <
200 pg/mL.
The high BNP group showed worse survival after 
corrective surgery for isolated, severe TR 
Thirty-eight patients underwent tricuspid valve replace-
ment and one patient underwent tricuspid valve repair and
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Table 3. Baseline characteristics according to BNP levels
BNP < 200 (n = 30) BNP ≥ 200 (n = 9) Significance
Age (year) 55.8 ± 1.9  55.3 ± 2.2 0.901
Female gender, n (%) 26 (86.7) 7 (77.8%) 0.607
BMI (kg/m
2) 21.5 ± 0.5 21.6 ± 0.8 0.976
SBP (mmHg) 113.4 ± 1.90 111.4 ± 4.60 0.655
Exercise capacity (sec) 732 ± 58 519 ± 91 0.138
NYHA Fc 0.007
II 14 1
III 15 5
IV 0 3
Previous operation 0.079
MVP 3 0
MVR 12 2
MVR + AVR 13 4
MVR + TAP or TVP  2 1
None 0 2
PASP (mmHg) 39.4 ± 1.6 39.0 ± 7.4 0.901
Atrial fibrillation, n (%)  26 (86.7) 7 (77.8) 0.607
Creatinine (mg/dL) 1.03 ± 0.04 1.26 ± 0.09 0.01
Cholesterol (mg/dL) 151 ± 60 111 ± 9 0.003
Albumin (g/dL) 4.0 ± 0.1 3.2 ± 0.2 0.002
Hemoglobin (g/dL) 12.1 ± 0.3 9.8 ± 0.8 0.002
Medication
Digoxin, n (%)  19 (63.3) 9 (100) 0.040
ACE inhibitor, n (%) 4 (13.3) 1 (11.1) 1.0
Beta-blocker, n (%) 3 (10) 3 (33.3) 0.123
Diuretics, n (%)  20 (66.7) 8 (88.9) 0.399
Spironolactone, n (%) 25 (83.3) 5 (55.6) 0.170
Values: mean ± SEM. BNP: B-type natriuretic peptide, BMI: body mass index, SBP: systolic blood pressure, exercise capacity: exercise time on treadmill by 
Bruce protocol, NYHA Fc: New York Heart Association Functional class, MVP: mitral valvuloplasty, MVR: mitral valve replacement, AVR: aortic valve
replacement, TAP: tricuspid annuloplasty, TVP: tricuspid valvuloplasty, PASP: estimated pulmonary artery systolic pressure by echocardiography
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Fig. 1. ROC curve for determining cut-off value to predict outcome after
surgery. ROC: receiver operating characteristic.annuloplasty. The median duration of follow-up after surgery
was 420 days (range, 11 - 780 days). Five of the 39 patients
died after surgery (1 patient in the lower BNP group and 4
patients in the higher BNP group); all of 5 patients died due
to congestive heart failure. Kaplan-Meier curves and log-rank
analysis revealed a significant difference between the 2 BNP
groups (p = 0.001)(Fig. 2). The 1-year survival rate was 96 ±
4% in patients with a BNP < 200 pg/mL, and 53 ± 17% in
patients with a BNP ≥ 200 pg/dL. Combined events, in-
cluding death and readmission due to congestive heart failure,
occurred in 12 among 39 patients during the follow-up period.
The patients with BNP < 200 pg/mL had fewer events within
1 year following surgery. Kaplan-Meier survival curves and
log-rank analysis showed a significant difference between the
two groups during follow-up (p= 0.049)(Fig. 3).   
D Di is sc cu us ss si io on n 
This is the first study to determine the BNP levels in pati-
ents with severe, isolated TR in relation to CMR parameters,
and to evaluate the role of BNP as a surrogate marker to
predict future outcomes after surgery. We found that the
following: (1) the BNP was determined by the LV EF and
RV ESVI in patients with severe, isolated TR; (2) a BNP ≥
200 pg/mL was the best cut-off value to predicted poor
outcome after corrective surgery; and (3) patients with a
BNP ≥ 200 pg/mL had higher mortality and morbidity after
surgery. 
The occurrence of functional TR after left-sided surgery is
not an infrequently event and is well-known to be closely
linked to exercise intolerance and to portend a poor prog-
nosis.
8)16)17) In an earlier study performed at our institution,
corrective TR surgery was associated with a high operative
mortality and morbidity.
4) Therefore, the decision on whe-
ther or not to proceed to TR surgery is difficult, which made
us search hemodynamic parameters of echocardiography and
CMR imaging predicting prognosis in patients with severe
TR.
3)4) In addition, we would like to have a simple and easily
available surrogate marker to predict the prognosis of pati-
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Table 4. CMR variables according to BNP levels
BNP < 200 (n = 30) BNP ≥ 200 (n = 9) Significance 
RV EDVI (mL/m
2) 187 ± 11 273 ± 28 0.002
RV ESVI (mL/m
2) 105 ± 70 169 ± 20 0.001
RV EF (%) 45.7 ± 1.9 40.0 ± 3.2 0.150
RV CI (L/min/m
2) 5.79 ± 0.34 6.84 ± 0.75 0.178
LV EDVI (mL/m
2) 94 ± 5 108 ± 16 0.431
LV ESVI (mL/m
2) 41 ± 4 62 ± 12 0.129
LV EF (%) 57.7 ± 2.2 43.1 ± 5.1 0.005
LV CI (L/min/m
2) 3.69 ± 0.16 3.26 ± 0.54 0.303
Values: mean ± SEM. CMR: cardiac magnetic resonance, BNP: B-type natriuretic peptide, RV: right ventricle, LV: left ventricle, EDVI: end diastolic volume 
index, ESVI: end systolic volume index, EF: ejection fraction, CI: cardiac index, LV: left ventricle 
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Fig. 2. Kaplan-Meier survival curve for death after surgery according to
BNP level. BNP: B-type natriuretic peptide.
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Fig. 3. Kaplan-Meier survival curve for death and re-admission due to
heart failure after surgery according to BNP level. BNP: B-type natriuretic
peptide.ents with severe, isolated TR. Patients with severe, isolated
TR need repeated evaluation because the isolated functional
TR normally occurs long after left-sided surgery. BNP acti-
vation is a well-known phenomenon in patients with heart
failure, but the role of BNP in patients with isolated func-
tion TR is not known. 
The BNP level was determined by the LV EF and RV
ESVI in the present study. In a previous study, BNP was
reported to be independent of LV and RV systolic function in
105 patients with RV or LV dysfunction by first-pass radio-
nuclide ventriculography and multiple ECG-gated equili-
brium radionuclide ventriculography, respectively.
18) Based
on multivariate analysis, the authors showed that only RVEF
and LVEF remained significant. In the present study, analyz-
ing patients with severe, isolated TR, we also arrived at the
same conclusion that the BNP level is dependent on LV and
RV systolic function. However, we found that not the RV EF,
but the RV ESVI, was a significant parameter in determin-
ing the BNP level using CMR imaging. Severe TR induces a
chronic volume overload of the RV, which leads to progressive
RV dilation, dysfunction, and finally RV failure. The patho-
physiologic sequence suggests that RV ESVI may be a more
sensitive factor to be associated with BNP elevation in patients
with severe TR. Our previous report showing that timely-
performed surgery for patients with severe functional TR
can preserve RV function (RV EF) also supports this idea.
3)
LV EF was the most important factor in determining
plasma BNP in patients with severe TR in the present study.
Pulmonary arterial pressure may be an important factor
which determines the hemodynamic significance of severe
TR. A low LV EF frequently elevates the pulmonary arterial
pressure, which may activate BNP. However, there was no
difference in terms of pulmonary artery pressure estimated
by echocardiography between the low BNP group and the
high BNP group. Therefore, the LV EF may have affected the
BNP level independent of RV function in the present study.   
The complex geometry of the RV is an obstacle to per-
forming research, because it is extremely difficult using
echocardiography to obtain accurate and reproducible infor-
mation regarding RV hemodynamics in a quantitative manner,
the technique most frequently used to assess cardiac haemo-
dynamics.
8) CMR imaging has emerged as a reference
standard imaging modality for quantitative assessment of RV
volumes, systolic function, and valve function.
19)20) With this
technology, we here attempted to determine the effects of
RV and LV hemodynamics on the BNP level in patients
with severe TR in the absence of left-sided valve dysfunction.
Study limitations
First, in most of our study subjects, the cause of TR was
functional and occurred late after left-sided valve surgery,
and thus our findings may not be directly applicable to TR
patients with other organic valve diseases. Second, because we
did not have a comparative group, we cannot conclude that
surgery is better than medical therapy for patients with
elevated BNP levels. This is an inherent limitation of clinical
studies involving valvular heart disease because of the relati-
vely low prevalence of the disease and the duration of time
required for the hemodynamic disturbance to affect chamber
remodeling and function. Finally, the cut-off value of the
BNP level by the ROC curve could not be validated in a sub-
sequent patient group because of the low prevalence of severe
TR. Despite these limitations, we believe that the values
suggested in the present study can aid in clinical decision-
making and can guide future research regarding this issue. 
In conclusion, the present study demonstrated that in pati-
ents with isolated, severe TR, an elevation in BNP level is
present and biologically active and reflects the hemodynamic
interaction of RV and LV. Furthermore, elevated levels of
BNP are independent predictors of mortality and morbidity
after corrective surgery. Thus, the BNP level emerged as a
biomarker of the severity of TR consequences and of poor
clinical outcome in patients with isolated TR. Measurement
of the BNP should be considered in patients with isolated
TR to support the clinical decision-making process. These
findings should be further evaluated in larger clinical trials.  
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